Senate panel summons price-hiking CEO of Turing Pharma

Thursday, November 5, 2015

WASHINGTON -- A Senate committee launched an investigation Wednesday into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines.

To continue reading
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.